SCHEDULE: Westfield Capital Boosts Stake in Bicycle Therapeutics

Westfield Capital Management Company, L.P. reports a 6.04% beneficial ownership stake in Bicycle Therapeutics PLC as of December 31, 2025.

Summary

• Westfield Capital Management Company, L.P. (Westfield Capital) has filed an Amendment No. 1 to Schedule 13G, disclosing its beneficial ownership in Bicycle Therapeutics PLC.
• As of December 31, 2025, Westfield Capital beneficially owns 3,016,026 shares of Bicycle Therapeutics PLC Common Stock.
• This ownership represents 6.04% of the class of securities.
• Westfield Capital holds sole voting power over 2,801,276 shares and sole dispositive power over 3,016,026 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, as it indicates significant institutional investment in Bicycle Therapeutics PLC, which can be a sign of investor confidence. However, it does not provide direct insights into the company's operational or financial performance.

Positives

• Increased institutional ownership by Westfield Capital Management Company, L.P. may signal confidence in Bicycle Therapeutics PLC's future prospects.
• The filing confirms that the shares are held in the ordinary course of business, indicating a long-term investment perspective rather than an activist stance.

Risks

• The filing itself does not detail specific company risks, but general market risks associated with holding common stock apply.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from Bicycle Therapeutics PLC.

Management Comments

• Westfield Capital Management Company, L.P. certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Bicycle Therapeutics PLC.

Industry Context

StockSavvy.ai notes that an increase in institutional ownership, particularly by an investment adviser like Westfield Capital, can be interpreted by the market as a vote of confidence in the company's strategy, pipeline, or overall market position within the biotechnology sector. Such filings provide transparency into significant investor positions.

Stakeholder Impact

• Shareholders may view the increased institutional ownership as a positive indicator, potentially leading to increased investor confidence and market stability for Bicycle Therapeutics PLC's stock.

Key Dates

Keywords

Bicycle Therapeutics, Westfield Capital Management, Schedule 13G, Beneficial Ownership, Institutional Investment, Common Stock, Biotechnology